Difficulty: Easy

Average Score: 100%

What is luminal A breast cancer characterized by?

Rationale

Slow-growth with a high cure rate.

Luminal A breast cancer is known for its relatively slow growth rate and favorable prognosis, often resulting in higher cure rates compared to more aggressive forms of breast cancer. This subtype typically has hormone receptor positivity, allowing for effective treatment options.

A (An overproduction of epidermal growth factor receptors) YOUR ANSWER

Luminal A breast cancer is characterized by low levels of HER2 expression, which is associated with overproduction of epidermal growth factor receptors. Instead, this subtype is characterized by hormone receptor positivity (estrogen and/or progesterone receptors), differentiating it from other aggressive forms of breast cancer that often overexpress HER2.

B (Aggressive invasion of blood vessels and lymph nodes) YOUR ANSWER

This choice describes a characteristic more associated with triple-negative or HER2-positive breast cancers, which are known for their aggressive nature and propensity for metastasis. In contrast, luminal A breast cancer typically exhibits less aggressive behavior, with a lower tendency for vascular and lymphatic invasion.

C (Slow-growth with a high cure rate) CORRECT

Luminal A breast cancer tends to grow slowly and has a high rate of treatability and cure, particularly when detected early. This characteristic is a key reason why patients with this subtype often have favorable outcomes compared to other breast cancer types.

D (Rapid and aggressive growth with a lack of estrogen and progesterone) YOUR ANSWER

This option inaccurately describes luminal A breast cancer, as this subtype is characterized by the presence of estrogen and/or progesterone receptors. Rapid growth and aggressiveness are hallmarks of other subtypes, such as triple-negative breast cancer, which lack these hormone receptors.

Conclusion

Luminal A breast cancer stands out due to its slow growth rate and high cure rate, primarily linked to its hormone receptor-positive status. This subtype presents a more manageable form of breast cancer, allowing for effective treatment strategies that capitalize on its biological characteristics, unlike the more aggressive subtypes that are defined by rapid growth and lack of hormonal receptors.

Related Questions

View all